TG Therapeutics, Inc. (TGTX)
30.57
-0.14
(-0.46%)
USD |
NASDAQ |
Jan 16, 16:00
30.80
+0.23
(+0.75%)
After-Hours: 20:00
TG Therapeutics EPS Diluted (Quarterly): 2.428 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| MannKind Corp. | 0.0256 |
| Karyopharm Therapeutics, Inc. | -3.821 |
| Axsome Therapeutics, Inc. | -0.9442 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 390.90M |
| Revenue (Quarterly) | 161.71M |
| Total Expenses (Quarterly) | -229.19M |
| Enterprise Value | 4.975B |
| Gross Profit Margin (Quarterly) | 82.59% |
| Earnings Yield | 9.09% |
| Operating Earnings Yield | 2.08% |
| Normalized Earnings Yield | 9.093 |